Cargando…
A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks
BACKGROUND: Non-pharmaceutical interventions (NPIs) are the cornerstone of infectious disease outbreak response in the absence of effective pharmaceutical interventions. Outbreak strategies often involve combinations of NPIs that may change according to disease prevalence and population response. Li...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192223/ https://www.ncbi.nlm.nih.gov/pubmed/34114184 http://dx.doi.org/10.1007/s40258-021-00659-z |
_version_ | 1783706014729633792 |
---|---|
author | Skarp, Janetta E. Downey, Laura E. Ohrnberger, Julius W. E. Cilloni, Lucia Hogan, Alexandra B. Sykes, Abagael L. Wang, Susannah S. Shah, Hiral Anil Xiao, Mimi Hauck, Katharina |
author_facet | Skarp, Janetta E. Downey, Laura E. Ohrnberger, Julius W. E. Cilloni, Lucia Hogan, Alexandra B. Sykes, Abagael L. Wang, Susannah S. Shah, Hiral Anil Xiao, Mimi Hauck, Katharina |
author_sort | Skarp, Janetta E. |
collection | PubMed |
description | BACKGROUND: Non-pharmaceutical interventions (NPIs) are the cornerstone of infectious disease outbreak response in the absence of effective pharmaceutical interventions. Outbreak strategies often involve combinations of NPIs that may change according to disease prevalence and population response. Little is known with regard to how costly each NPI is to implement. This information is essential to inform policy decisions for outbreak response. OBJECTIVE: To address this gap in existing literature, we conducted a systematic review on outbreak costings and simulation studies related to a number of NPI strategies, including isolating infected individuals, contact tracing and quarantine, and school closures. METHODS: Our search covered the MEDLINE and EMBASE databases, studies published between 1990 and 24 March 2020 were included. We included studies containing cost data for our NPIs of interest in pandemic, epidemic, and outbreak response scenarios. RESULTS: We identified 61 relevant studies. There was substantial heterogeneity in the cost components recorded for NPIs in outbreak costing studies. The direct costs of NPIs for which costing studies existed also ranged widely: isolating infected individuals per case: US$141.18 to US$1042.68 (2020 values), tracing and quarantine of contacts per contact: US$40.73 to US$93.59, social distancing: US$33.76 to US$167.92, personal protection and hygiene: US$0.15 to US$895.60. CONCLUSION: While there are gaps and heterogeneity in available cost data, the findings of this review and the collated cost database serve as an important resource for evidence-based decision-making for estimating costs pertaining to NPI implementation in future outbreak response policies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40258-021-00659-z. |
format | Online Article Text |
id | pubmed-8192223 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-81922232021-06-11 A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks Skarp, Janetta E. Downey, Laura E. Ohrnberger, Julius W. E. Cilloni, Lucia Hogan, Alexandra B. Sykes, Abagael L. Wang, Susannah S. Shah, Hiral Anil Xiao, Mimi Hauck, Katharina Appl Health Econ Health Policy Systematic Review BACKGROUND: Non-pharmaceutical interventions (NPIs) are the cornerstone of infectious disease outbreak response in the absence of effective pharmaceutical interventions. Outbreak strategies often involve combinations of NPIs that may change according to disease prevalence and population response. Little is known with regard to how costly each NPI is to implement. This information is essential to inform policy decisions for outbreak response. OBJECTIVE: To address this gap in existing literature, we conducted a systematic review on outbreak costings and simulation studies related to a number of NPI strategies, including isolating infected individuals, contact tracing and quarantine, and school closures. METHODS: Our search covered the MEDLINE and EMBASE databases, studies published between 1990 and 24 March 2020 were included. We included studies containing cost data for our NPIs of interest in pandemic, epidemic, and outbreak response scenarios. RESULTS: We identified 61 relevant studies. There was substantial heterogeneity in the cost components recorded for NPIs in outbreak costing studies. The direct costs of NPIs for which costing studies existed also ranged widely: isolating infected individuals per case: US$141.18 to US$1042.68 (2020 values), tracing and quarantine of contacts per contact: US$40.73 to US$93.59, social distancing: US$33.76 to US$167.92, personal protection and hygiene: US$0.15 to US$895.60. CONCLUSION: While there are gaps and heterogeneity in available cost data, the findings of this review and the collated cost database serve as an important resource for evidence-based decision-making for estimating costs pertaining to NPI implementation in future outbreak response policies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40258-021-00659-z. Springer International Publishing 2021-06-11 2021 /pmc/articles/PMC8192223/ /pubmed/34114184 http://dx.doi.org/10.1007/s40258-021-00659-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Systematic Review Skarp, Janetta E. Downey, Laura E. Ohrnberger, Julius W. E. Cilloni, Lucia Hogan, Alexandra B. Sykes, Abagael L. Wang, Susannah S. Shah, Hiral Anil Xiao, Mimi Hauck, Katharina A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks |
title | A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks |
title_full | A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks |
title_fullStr | A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks |
title_full_unstemmed | A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks |
title_short | A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks |
title_sort | systematic review of the costs relating to non-pharmaceutical interventions against infectious disease outbreaks |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192223/ https://www.ncbi.nlm.nih.gov/pubmed/34114184 http://dx.doi.org/10.1007/s40258-021-00659-z |
work_keys_str_mv | AT skarpjanettae asystematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks AT downeylaurae asystematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks AT ohrnbergerjuliuswe asystematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks AT cillonilucia asystematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks AT hoganalexandrab asystematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks AT sykesabagaell asystematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks AT wangsusannahs asystematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks AT shahhiralanil asystematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks AT xiaomimi asystematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks AT hauckkatharina asystematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks AT skarpjanettae systematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks AT downeylaurae systematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks AT ohrnbergerjuliuswe systematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks AT cillonilucia systematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks AT hoganalexandrab systematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks AT sykesabagaell systematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks AT wangsusannahs systematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks AT shahhiralanil systematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks AT xiaomimi systematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks AT hauckkatharina systematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks |